Patient-driven outreach is here.

Glycogen Storage Disease 1a (GSD 1a) is a rare genetic disorder that affects the body's ability to manage glucose, leading to symptoms like low blood sugar, growth delays, and liver problems. Despite its serious impacts, many individuals remain undiagnosed, affecting their quality of life. If you or someone you know is affected by GSD 1a, join our movement to share resources and support.

Meet the Team

Will Raasch

Founder, CEO

Will began his career working at the FDA Office of Orphan Drug Products. While there, he led an internal study to determine why drug candidates for rare disease patients were not approved. A surprisingly large proportion of these drugs were abandoned because of an inability to find patients. After the FDA, Will spent 7 years at Baxter Healthcare, eventually managing all US production of rare disease plasma products, leading a staff of 100 personnel and a budget of $20 million. After reading about the MIT initiative to find “needle-in-a-haystack” targets, he contacted the lab, left Baxter, built WeHealth to connect patients with advocacy groups and clinical research, solving the problem that he observed at the FDA. Will holds a BS in Biological Sciences from Stanford University and an MBS in Biotechnology from Keck Graduate Institute.

Mahrad Saeedi

Co-Founder, COO

Mahrad's passions are deeply rooted in supporting health equity initiatives to connect underserved patient communities with resources and support. His breadth of experience enables him to provide a unique perspective in partnering with patients, researchers and physicians to streamline the healthcare continuum using digital solutions. Prior to co-founding WeHealth, Mahrad worked as a management consultant for Eversana, where he partnered with life sciences companies to deliver strategic business solutions and enable broad access to innovative treatments. While there, he noticed pharma's clear inability to mobilize digital solutions for discovering and developing treatments, which further hindered product launches and patient access to timely treatment. Through WeHealth, Mahrad strives to empower patients with access to resources, treatment and support by building patient-driven communities for healing together. Mahrad earned his BS in Biology from Loyola Marymount University in Los Angeles, Ca and his MBS in biotech management from Keck Graduate Institute in Claremont, Ca.

How it Works


We launch campaigns that connect under-served patients with support and treatment opportunities


You only need to share with 1-2 friends to have an impact


We map how your shares spread and target them to under-served patients in your network


You can see your impact when we help under-served patients due to your sharing